fbpx
Learn2Health: Learn about Diabetes and Healthy Meal Planning

Having Severe Hypertriglyceridemia: Lower Triglycerides & Improve Liver Health with Pegozafermin

About The Study

This study is for individuals with very high levels of triglycerides (a type of fatty substance in the blood). This is called severe hypertriglyceridemia. Individuals are thought to have this condition when their blood triglyceride levels are above 500 mg/dL.

Participants in this study will start taking either a once-weekly investigational injection or placebo. The investigational med is called pegozafermin and is currently not approved by the FDA. In previous studies, Pegozafermin has shown the ability to lower blood triglycerides and decrease abnormal fat storage in the liver. Participants have a 75% chance of receiving pegozafermin or a 25% chance of receiving placebo.

The purpose of this study is to learn about the safety and effectiveness of the research drug on triglyceride levels, cholesterols, fatty proteins, blood sugars, and organs like the liver.

To take part in the study, participants should be:

  • Have very high levels of triglycerides
  • 22 years of age or older
See if you qualify
Study Image

What Is a Study?

  • A clinical study helps advance the future of diabetes! Research patients try new meds or devices not yet available to the public, at no cost to them.
  • Research patients meet with a study coordinator and doctor multiple times to monitor them.
  • Each visit, patients are compensated for travel expenses.
  • Study patients must meet a list of criteria in order to be a part of a study.
  • A study can last anywhere from six months to a few years.

Join this study!

If you want to see if you qualify for a study, share your information and we will contact you. Want to speak with someone immediately? Call (515) 329-5690.

Please enter your first name.
Please enter your last name.
Please enter a valid phone number.
Please enter a valid email address.

Benefits


Receive free medications and free supplies!

Gain better understanding of your disease and take an active role in your health.

Obtain treatments not yet available and contribute to medical research.

Travel stipends for attending most scheduled research appointments.

On average patients receives free care worth $250 - $500 from diabetes experts.

So far Iowa Diabetes Research has spent more than $500K on patients benefits

Our Caring Team

Anuj Bhargava

Dr. Anuj Bhargava

CEO and Medical Director

Christine Burke

Christine Burke

Director of Clinical Services

Tara Herrold

Tara Herrold

Director of Clinical Research

Lisa Borg

Lisa Borg

Clinical Research Coordinator

Natalie Young

Natalie Young

Clinical Research Coordinator

Kendra Ridenour

Kendra Ridenour

Navigator/Study Start-up Manager

Kara Turner

Kara Turner

Clinical Research Coordinator

Allie Fowler

Allie Bohr

Clinical Research Coordinator

Have questions?

Call us at (515) 329-6800

Email us at info@iowadiabetes.com.